The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Monogram Biosciences Inc. (MGRM)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Cutting loss

May 10, 2007 06:41 PM GMT
Return Risk
-7.69% HIGH
Sr. Analyst

I still like the company long term, but going out for now.  there's lack of catalyst in the ext yr or so.  The closest I think is the increased revenue from Trofile/CCR5 Maraviroc tie in.  In the long term, the cancer assays have the biggest potentials, but investors have to be really patient for it.

MGRM:  This call was made on 05/10/07 @ $9.78
Rating:   Negative   $9.78 (05/10/07)
Closed:   05/17/2007 @ $9.6 (+1.84% in 7 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.36% 531
2 Gerald Greene 18.14 +36.28% 286
3 stockmarketfunding.com 17.66 +23.07% 83
4 akiralegrand 13.47 +13.37% 69
5 anup2104 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment
ETFC E*Trade Financial Corp
GE General Electric Company
GS Goldman Sachs Group Inc The
MO Altria Group Inc
FNM Fannie Mae
NVDA NVIDIA Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Monogram Biosciences Inc. (MGRM)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
91.5%
Top:
100.0%




Latest Picks by kuntilanak
Symbol SP Sentiment Rating Return Since
HDNG Positive -73.82% 07/18/07
NTAP Positive +9.47% 07/18/07
DIVX Positive n/a 05/23/07
CHINA Positive n/a 05/23/07
SNDA Positive n/a 05/23/07

View All >
   
kuntilanak previously rated MGRM
Positive -35.83% Potential Upside with Trofile/Maraviroc
04/20/2007
7
Positive +38.04% Potential upsode with Trofile/Maraviroc
04/16/2007
1





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch